for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Hanmi Science Co Ltd

008930.KS

Latest Trade

59,700.00KRW

Change

500.00(+0.84%)

Volume

30,065

Today's Range

58,700.00

 - 

60,000.00

52 Week Range

51,764.70

 - 

96,600.00

As of on the Korea Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
59,200.00
Open
59,000.00
Volume
30,065
3M AVG Volume
3.09
Today's High
60,000.00
Today's Low
58,700.00
52 Week High
96,600.00
52 Week Low
51,764.70
Shares Out (MIL)
65.95
Market Cap (MIL)
3,984,433.00
Forward P/E
--
Dividend (Yield %)
0.33

Next Event

Q3 2021 Hanmi Science Co Ltd Earnings Release

Latest Developments

More

Hanmi Science Announces Bonus Issue Of 1.2 Mln New Shares

Hanmi Science says issuance of 4 mln bonus shares

Hanmi Science unit Hanmi Pharm says issuance of 728,341 bonus shares

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Hanmi Science Co Ltd

Hanmi Science Co Ltd is a Korean-based holding company principally involved in the management of subsidiaries. Through subsidiaries in Japan, Europe and Korea, the Company operates in three segments. The Pharmaceutical Products Wholesale segment mainly engages in the distribution of pharmaceutical products. The Holding Business segment mainly engages in the business of controlling subsidiaries. The Other segment mainly engage in the production and sales of pharmaceuticals, and the supply of quasi-drugs and health functional foods, beverages and functional cosmetics.

Industry

Major Drugs

Contact Info

214, Muha-ro, Paltan-myeon

18536

South Korea

+82.31.3505600

http://www.hanmiscience.co.kr/

Executive Leadership

Yeong Suk Song

Chairman of the Board, Co-Chief Executive Officer

Jong Yun Yim

Co-President, Co-Chief Executive Officer, Director

Se Chang Gwon

Co-President, Director

Jong Su Woo

Co-President, Director

Jong Ho Yim

Managing Director

Key Stats

Price To Earnings (TTM)
127.82
Price To Sales (TTM)
4.50
Price To Book (MRQ)
5.80
Price To Cash Flow (TTM)
110.72
Total Debt To Equity (MRQ)
8.88
LT Debt To Equity (MRQ)
0.05
Return on Investment (TTM)
4.42
Return on Equity (TTM)
3.32

Latest News

Latest News

Exclusive: South Korea in talks with mRNA vaccine makers to make up to 1 billion doses -government official

South Korea is in talks with mRNA vaccine makers including Pfizer and Moderna to produce COVID-19 shots in the country and is ready to offer the capacity to make up to 1 billion doses immediately, a senior government official said.

EXCLUSIVE-S.Korea in talks with mRNA vaccine makers to make up to 1 bln doses -govt official

South Korea is in talks with mRNA vaccine makers including Pfizer and Moderna to produce COVID-19 shots in the country and is ready to offer the capacity to make up to 1 billion doses immediately, a senior government official said.

S.Korean stocks snap 4-day losing streak as U.S. rate cut bets rise

Round-up of South Korean financial markets: ** South Korean stocks snapped a four-session losing streak to end higher on Thursday, boosted by rising hopes of a rate cut by the U.S. Federal Reserve, in a choppy session due to caution ahead of Samsung Electronic's second-quarter...

S.Korea stocks steady; weak pharmaceutical shares cap gains

* KOSPI index steady, foreigners net buyers * Korean won strengthens versus U.S. dollar * South Korea benchmark bond yield rises SEOUL, July 4 (Reuters) - Round-up of South Korean financial markets: ** South Korea's KOSPI stock index was flat on Thursday, as a sharp fall...

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up